文献速递消化内镜消化道出血

低血栓风险患者胃ESD围手术期继续低剂量阿司匹林:随机试验

Low-Dose Aspirin Continuation During Gastric Endoscopic Submucosal Dissection in Patients With Low Thrombotic Risk: A Randomized Trial.
PubMed 文献 · Am J Gastroenterol · 2026-01-22

本研究纳入551例服用低剂量阿司匹林(LDA)且血栓风险低的胃黏膜肿瘤患者,随机分为停药组与继续组,比较ESD相关大出血发生率。继续组大出血发生率为10%,停药组为7.6%,风险差2.5%(90%CI上限6.6%),超过预设非劣效界值5%(P=0.157),非劣效性未成立。

要点

  • 低血栓风险患者胃ESD围手术期继续LDA未达到非劣效于停药。
  • 继续组大出血风险差2.5%,90%CI上限6.6%超过5%非劣效界值。
  • 继续组有2例脑梗死,但研究未证明继续LDA的非劣效性。

核心结论

  • 在低血栓风险患者中,胃ESD围手术期继续LDA相比停药未达到非劣效性。
  • 因此推荐低血栓风险患者胃ESD围手术期停用LDA。

研究设计与样本

  • 随机对照试验,纳入551例服用LDA且血栓风险低的胃黏膜肿瘤患者。
  • 患者随机分为停药组(n=276)和继续组(n=275),主要终点为ESD相关大出血。

主要发现

  • 改良意向治疗分析中,停药组ESD相关大出血发生率为7.6%(95%CI 4.8-11),继续组为10%(95%CI 6.9-14)。
  • 风险差为2.5%(95%CI -2.3至7.4),双侧90%CI上限为6.6%,超过预设非劣效界值5%(P=0.157)。
  • 符合方案分析风险差为4.4%(95%CI -0.5至9.5),支持阴性结果。
  • 继续组有2例患者发生脑梗死。

关键数值与推荐

  • 非劣效界值Δ为5%。
  • 主要终点ESD相关大出血风险差2.5%(90%CI上限6.6%),非劣效性未成立(P=0.157)。

临床怎么用

  • 对于低血栓风险患者,胃ESD围手术期建议停用LDA。
  • 继续LDA未显示非劣效性,且继续组出现脑梗死事件,需个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The recommendation to discontinue low-dose aspirin (LDA) during the periprocedural period of endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) remains controversial in patients at low thrombotic risk. If continuation of LDA does not increase bleeding risk, gastric ESD could be safely performed under sustained antiplatelet effects, benefiting patients. This study aimed to evaluate whether continuation of LDA is noninferior to discontinuation regarding ESD-related bleeding risk in patients with low thrombotic risk. METHODS: Patients with gastric mucosal neoplasms and low thrombotic risk who were taking LDA were eligible. Participants were randomly assigned to either the discontinuation or continuation group. No prophylaxis was performed except for cauterizing exposed vessels at the ulcer base. The primary end point was the incidence of ESD-related major bleeding. RESULTS: A total of 551 patients were enrolled. In the modified intent-to-treat analysis, the incidence of ESD-related major bleeding (95%) was 7.6% (4.8-11) in the discontinuation group (n = 276) and 10% (6.9-14) in the continuation group (n = 275), yielding a risk difference of 2.5% (-2.3 to 7.4). The upper limit of the 2-sided 90% confidence interval (6.6%) exceeded the predefined noninferiority margin (Δ5%, P = 0.157). The per-protocol analysis supported this negative result, with a risk difference of 4.4% (-0.5 to 9.5). Two patients in the continuation group developed cerebral infarction. DISCUSSION: The noninferiority of LDA continuation over discontinuation for ESD-related major bleeding in gastric ESD was not demonstrated. Therefore, discontinuation of LDA during the periprocedural period is recommended for patients with low thrombotic risk (UMIN000013177).

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Uedo N, Gotoda T, Takizawa K, et al. Low-Dose Aspirin Continuation During Gastric Endoscopic Submucosal Dissection in Patients With Low Thrombotic Risk: A Randomized Trial. Am J Gastroenterol. 2026. PMID: 41568818. doi:10.14309/ajg.0000000000003928

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。